Ventana Unveils the Latest in Digital Pathology and Lab Workflow Solutions at IAP 2012 in Cape Town
Article Sep 26, 2012
At this year's 29th Congress of the International Academy of Pathology (IAP 2012), Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will unveil the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab specimen tracking. IAP 2012, one of the premier pathology conferences worldwide, takes place September 30 through October 5, 2012 in Cape Town, South Africa.
"I am thrilled to be presenting our latest products at this year's IAP," explained Steve Burnell, PhD, Lifecycle Leader for Digital Pathology and Workflow for Ventana Medical Systems, Inc. "The global adoption of digital pathology and lab workflow solutions is gaining momentum, driven by benefits to laboratory efficiency and productivity, as well as improvements in patient care. As the established innovation leader in these areas, the Ventana launch of Virtuoso 5.3 – with a user interface now available in 21 languages – and VANTAGE 2.2 – with improved integration, underscores our commitment to pathologists, laboratory staff and patients to deliver the most innovative products in the industry."
Virtuoso web-based software orchestrates the digital slide workflow from the moment the slide is scanned until the slide image is viewed and the case results reported. With Virtuoso 5.3, Ventana has expanded the user interface to 21 languages, making it easy for international customers to adopt this new technology.
"I am pleased to see Ventana continue to take a leadership role in digital pathology with the latest offering of its Virtuoso software released in multiple languages. This is a reflection of the strong interest in digital pathology from labs across the globe. Virtuoso not only increases the effectiveness of labs like mine working with cases from Mexico and the US, but also enables us to improve patient care." Jesus Ellin – Yuma Regional Medical, Yuma, AZ USA.
The market-leading VANTAGE workflow solution automates, streamlines, and integrates lab work and information flow to provide increased productivity and patient safety gains. The VANTAGE 2.2 release introduces increased Laboratory Information System (LIS) integration capabilities, touchscreen workflow enhancements and case assembly improvements in response to global customers' needs. Through its integration with Virtuoso software, the VANTAGE workflow solution enables pathologists and lab managers to track the progress of a slide from preparation to digitization along with other critical slide information, giving a lab unprecedented visibility into its processes and tools to optimize lab workflow.
Ventana's newest scanner, the VENTANA iScan HT slide scanner, will also be showcased at IAP 2012. The VENTANA iScan HT is the most powerful scanner in anatomic pathology today, enabling pathologists and lab managers to optimize their digital pathology workflow with efficiency, convenience, speed, throughput and reliability for unprecedented results. The VENTANA iScan HT slide scanner is ideal for high throughput and high volume applications. It complements the VENTANA comprehensive suite of digital pathology solutions which also includes the iScan Coreo slide scanner, Virtuoso software, and the most comprehensive portfolio of research use only (RUO), CE-IVD and FDA-cleared 510(k) image analysis algorithms available.
"Since the acquisition of BioImagene two years ago, Roche and Ventana have invested heavily in Digital Pathology, bringing a wide range of innovative new products to the market. We believe that by driving the rapid adoption of digital pathology and improved workflow globally, we will help improve patient care. Our customers can expect sustained and unparalleled innovation from Ventana in the future," says Mara G. Aspinall, President of Ventana Medical Systems, Inc.
To view the entire suite of Ventana digital pathology and workflow products, including the Virtuoso -VANTAGE software integration, visit the Roche Diagnostics booth during the 29th Congress of the International Academy of Pathology from September 30th through October 5th, 2012 in Cape Town, South Africa.
Untargeted metabolomics approaches are allowing previously unreported insights into the pathogenesis of disease. However, identifying the large numbers of unknown and structurally diverse metabolites typically present in biological samples has proven to be a major bottleneck. Fortunately, recent advances in technology and software are helping to overcome this challenge.READ MORE
The UK’s national health system needs to take a hard look at their priorities and procedures to ensure that rapid advances in molecular diagnostics in lung cancer are translated into a practical service for all patients, according to a report launched at the British Thoracic Oncology Group Annual Conference.READ MORE
First developed in the 1970s, recent developments are making microflow liquid chromatography techniques more robust – enticing researchers to revisit the opportunities it offers for more sensitive, high-throughput analyses requiring smaller sample volumes than standard flow techniques.READ MORE